James Condulis Analyst PerformanceVice President - Biotechnology Equity Research at Stifel NicolausJames Condulis is a stock analyst at Stifel Nicolaus in the medical sector, covering 9 publicly traded companies. Over the past year, James Condulis has issued 12 stock ratings, including buy and hold recommendations. While full access to James Condulis' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights James Condulis' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings16 Last 1 YearsBuy Recommendations85.71% 12 Buy RatingsCompanies Covered9 Unique Companies Ratings Distribution14RatingsDistribution of strong buy, buy, hold, and sell ratings by James Condulis.RatingPercentageCount Strong Buy0.0%0 ratings Buy85.7%12 ratings Hold14.3%2 ratings Sell0.0%0 ratingsOut of 14 total stock ratings issued by James Condulis at Stifel Nicolaus, the majority (85.7%) have been Buy recommendations, followed by 14.3% Hold.Best & Worst CallsBest Call000.0%CYTKJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SLNOMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ9 companiesJames Condulis, an analyst at Stifel Nicolaus, currently covers 9 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical9 companies100.0%James Condulis of Stifel Nicolaus specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE6 companies66.7%MED - DRUGS3 companies33.3% James Condulis' Ratings History at Stifel Nicolaus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMIRMMirum Pharmaceuticals5/7/2026Set Price Target$101.07$136.00$0.0000.00% ROICYTKCytokinetics5/6/2026Boost Price Target$75.19$108.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals4/29/2026Boost Price Target$94.00$130.00Buy$0.0000.00% ROITECXTectonic Therapeutic4/13/2026Initiated Coverage$29.96$75.00Buy$0.0000.00% ROIAMLXAmylyx Pharmaceuticals3/3/2026Initiated Coverage$15.30$21.00Buy$0.0000.00% ROIAARDAardvark Therapeutics3/2/2026Reiterated Rating$12.49$6.00Hold$0.0000.00% ROIEWTXEdgewise Therapeutics2/26/2026Set Price Target$29.90$25.00$0.0000.00% ROINAMSNewAmsterdam Pharma12/16/2025Boost Price Target$34.97$50.00Buy$0.0000.00% ROIXFORX4 Pharmaceuticals12/5/2025Set Price Target$3.80$10.00Buy$0.0000.00% ROIAARDAardvark Therapeutics9/29/2025Initiated Coverage$13.23$24.00Buy$0.0000.00% ROICYTKCytokinetics9/2/2025Boost Price Target$47.85$96.00Buy$0.0000.00% ROINAMSNewAmsterdam Pharma6/10/2025Initiated Coverage$20.16$44.00Buy$0.0000.00% ROISLNOSoleno Therapeutics3/28/2025Boost Price Target$70.64$108.00Buy$00.0000.00% ROISLNOSoleno Therapeutics3/5/2025Initiated Coverage$45.12$74.00Buy$00.0000.00% ROICYTKCytokinetics1/22/2025Initiated Coverage$45.82$80.00Buy$00.0000.00% ROIEWTXEdgewise Therapeutics1/22/2025Initiated Coverage$27.39$30.00Hold$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupMorgan StanleyRoyal Bank Of CanadaJefferies Financial GroupThe Goldman Sachs GroupStifel NicolausRaymond James FinancialMizuhoBank of AmericaKeyCorpSanford C. BernsteinWolfe ResearchCICC Research Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
